(Q43890873)

English

A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

hepatic veno-occlusive disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Park SH

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Lee MH

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Lee H

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Kim HS

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Kim K

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Kim WS

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Jung CW

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Im YH

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Yoon SS

9

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Kang WK

10

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Park K

11

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Park CH

12

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Kim SW

13

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

137-143

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

randomized experiment

0 references

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1703342

0 references

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703342

21 January 2018

Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703342

21 January 2018

Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703342

21 January 2018

Low molecular weight heparin for the prevention of veno-occlusive disease of the liver in bone marrow transplantation patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703342

21 January 2018

Use of prostaglandin E1 for prevention of liver veno-occlusive disease in leukaemic patients treated by allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703342

21 January 2018

Venoocclusive disease of the liver following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703342

7 January 2021

based on heuristic

inferred from DOI database lookup

Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703342

7 January 2021

based on heuristic

inferred from DOI database lookup

Regimen-related toxicity in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703342

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703342

7 January 2021

based on heuristic

inferred from DOI database lookup

Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703342

7 January 2021

based on heuristic

inferred from DOI database lookup

The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703342

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I/II study of prostaglandin E1 for the prevention of hepatic venocclusive disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1703342

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1703342

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43890873&oldid=2104183348"